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sUmmARy – There are no reliable data on the relationship between ischemic stroke and ele-
vated triglyceride levels. Results of previous studies have shown that elevated total cholesterol, high 
low-density lipoprotein cholesterol (ldl-C) and low high-density lipoprotein cholesterol (Hdl-
C) are modifiable risk factors for ischemic stroke. Recent evidence suggests that hypertriglyceri-
demia correlates with an increased risk of cardiovascular disease, particularly if the levels of Hdl 
cholesterol are low and the levels of ldl cholesterol are high. The role of hypertriglyceridemia as an 
independent risk factor for stroke remains questionable, although correlation between elevated tri-
glycerides and recurrent ischemic stroke has been established. Hypertriglyceridemia is an essential 
feature of metabolic syndrome, the most important risk factor for atherosclerosis and prothrombotic 
state, and both correlate with the increased risk of stroke. lowering triglyceride levels might have a 
positive effect in stroke risk reduction. efficacy of gemfibrozil was demonstrated in secondary stroke 
prevention in patients with coronary heart disease and elevated triglyceride levels. Fibrate derivati-
ves might be utilized in primary stroke prevention, but their efficacy has not yet been established. 
There is substantial evidence to conclude that hypertriglyceridemia might be an independent risk 
factor for stroke, but additional studies are mandatory to confirm this presumption.
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Introduction
The possible role of hypertriglyceridemia as a 
possible risk factor for ischemic stroke remains con-
troversial. However, a growing body of evidence in-
dicates that hypertriglyceridemia is associated with 
atherosclerosis, endothelial dysfunction and pro-
thrombotic state that may contribute to an increased 
risk of ischemic stroke. Recent evidence indicates 
that hypertriglyceridemia may correlate with an 
increased risk of cardiovascular events, particularly 
if high-density lipoprotein cholesterol (Hdl-C) is 
low and low-density lipoprotein cholesterol (ldl-
C) is high, or both1-3. According to the Third Report 
of the national Cholesterol educational program 
and the Adult treatment panel (nCep-Atp iii), 
hypertriglyceridemia is classified at the following 
values: normal (1.7 mmol/l); borderline-high (1.7-
2.2 mmol/l); high (2.2-5.6 mmol/l); and very high 
(≥5.6 mmol/l)4. The atherogenic lipoprotein profile 
might be accentuated by the mutations of lipoprotein 
lipase, which plays an important role in degradation 
of triglycerides and synthesis of precursors of Hdl-
C particles5. elevated serum levels of total choles-
terol and ldl, along with low levels of Hdl are 
recognized but modifiable risk factors for ischemic 
stroke. However, there are no reliable data on the 
relationship of ischemic stroke and elevated triglyc-
erides in serum, thus there is no consensus on the 
importance of hypertriglyceridemia as an indepen-
dent risk factor for ischemic stroke.
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Hypertriglyceridemia and the Possible 
Mechanisms of Ischemic Stroke
Atherosclerosis and thrombosis are credible mech-
anisms by which hypertriglyceridemia might cause 
ischemic stroke. Recent data show that postprandial 
hypertriglyceridemia in diabetic patients affects en-
dothelial dysfunction by disturbing the mechanism of 
vasodilatation and promoting oxidative stress6. Cor-
relation of hypertriglyceridemia and increased inflam-
matory markers in systemic inflammation, especially 
C-reactive protein, increases the risk of cardiovascular 
events, particularly for the coronary heart disease7-9.
numerous studies have shown that carotid intima-
media thickness (Cimt) is a reliable indicator of ear-
ly atherosclerosis that is also associated with elevation 
of inflammatory markers, fibrinogen and circulating 
adhesion molecules, each individually being related to 
hypertriglyceridemia. prothrombotic state is associ-
ated with hypertension and dyslipidemia, both hav-
ing a significant effect on Cimt, particularly in the 
elderly10. in the Framingham Heart study, triglycer-
ide levels before meal were not associated with carotid 
atherosclerosis but the association of postprandial hy-
pertriglyceridemia and Cimt was confirmed in sub-
jects with type 2 diabetes11,12. Hypertriglyceridemia 
induces cerebrovascular events by the mechanism of 
thrombosis, due to changes in coagulation cascade and 
by increasing plasma viscosity. elevated fibrinogen is 
a strong and independent risk factor that is associated 
with progression of carotid disease and consequent 
vascular events13. elevated levels of triglycerides, fi-
brinogen, total protein, ldl-C and total cholesterol 
are independently and positively correlated with in-
creased plasma viscosity14. Hyperviscosity may lead to 
tissue ischemia due to disturbance of microcirculation 
and endothelial dysfunction, thus increasing the risk 
of thrombosis and promoting stroke15.
Triglycerides and Metabolic Syndrome
Hypertriglyceridemia is an important part of 
metabolic syndrome, which significantly increases the 
risk of cardiovascular and vascular events. Features of 
metabolic syndrome, defined by Atp iii and World 
Health organization, include abdominal obesity 
(waist circumference), Hdl-C levels (<2.2 mmmol/l 
in men and <2.8 mmol/l in women), hypertension 
(>130/85 mmHg), pre-meal glucose levels (>6.1 
mmol/l) and triglyceride levels (>1.7 mmol/l)4. met-
abolic syndrome is associated with myocardial infarc-
tion and stroke, but the role of hypertriglyceridemia 
in metabolic syndrome as an independent risk factor 
for stroke is not entirely clear. metabolic syndrome 
with pronounced dyslipidemia is the most important 
risk factor for atherosclerosis. it is associated with pro-
thrombotic state and hyperinsulinemia, which further 
affects platelet function, coagulation and fibrinoly-
sis16,17. patients with poorly controlled diabetes have 
higher triglyceride levels than those who are well con-
trolled. postprandial hyperlipidemia and exposure to 
atherogenic particles is prolonged in diabetic patients, 
thus subjects with diabetes and hypertriglyceridemia 
have increased mortality mostly due to coronary heart 
disease, which is particularly pronounced in middle-
aged men18,19. subjects with metabolic syndrome had 
a higher risk of stroke, ischemic heart disease and dia-
betes. When analyzed separately, hypertension was 
significantly associated with stroke, ischemic heart 
disease and diabetes, while hypertriglyceridemia and 
hyperglycemia were significantly associated only with 
ischemic heart disease and diabetes20.
Triglycerides and the Risk of Stroke
several studies have indicated that elevated triglyc-
erides are not an independent risk factor for ischemic 
stroke21,22. The Atherosclerosis Risk in Communities 
(ARiC) study showed weak and inconsistent correla-
tion of triglyceride levels and ischemic stroke. sub-
jects without clinically manifest cardiovascular dis-
ease were included and results of the study showed no 
significant association between ischemic stroke and 
elevated lipid levels23. studies conducted in the elderly 
showed that triglyceride levels were not a significant 
risk factor for ischemic stroke or transient ischemic 
attack (tiA)24,25. Results of some other studies have 
confirmed positive correlation between hypertriglyc-
eridemia and ischemic stroke. The blood lipids and 
First-ever ischemic stroke/transient ischemic Attack 
in the bezafibrate prevention study (bip) showed that 
hypertriglyceridemia was an independent risk factor 
for ischemic stroke or tiA in patients with coronary 
heart disease26. A meta-analysis conducted by the 
Asia-pacific Cohort studies Collaboration (ApCsC) 
showed significant correlation of serum triglycerides 
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and fatal and non-fatal combined ischemic stroke, 
independently of other risk factors27. significant cor-
relation of triglyceride levels and stroke was found in 
women in comparison with men for each triglyceride 
level increase28. The Copenhagen City Heart study 
showed strong linear association between triglyceride 
levels and relative risk of ischemic events (ischemic 
stroke or tiA) for each triglyceride level increase29.
Hypertriglyceridemia and Ischemic Stroke 
Subtypes
Association of hypertriglyceridemia and different 
ischemic stroke subtypes is not utterly clear. several 
studies have addressed lipid profile in different sub-
types of ischemic stroke. Cardiovascular events were 
caused by cardio emboli in 48% of patients with in-
creased triglyceride levels and atherosclerotic artery 
disease of large and small arteries30,31. metabolic syn-
drome was significantly associated with silent brain 
infarcts, particularly in middle-aged patients without 
previous history and clinical symptoms of stroke32. 
significant correlation of metabolic syndrome and 
silent brain infarction, periventricular and subcorti-
cal white matter lesions was also detected in appar-
ently healthy subjects33. According to the components 
of metabolic syndrome, hypertension was associated 
with all types of lesions, while dyslipidemia and hy-
perglycemia were associated with subcortical white 
matter lesions and periventricular hyperintensities. 
metabolic syndrome was associated with the preva-
lence of stroke independently of other risk factors, and 
synergistic effect of metabolic syndrome components 
was associated with the prevalence of silent brain in-
farcts33. silent brain infarct might announce clinically 
manifest stroke or dementia. A study conducted in 
apparently healthy subjects showed that more than 5% 
of cases had more than one lacunar ischemic lesion on 
magnetic resonance imaging34. Age was significantly 
associated with the prevalence of silent stroke, while 
coronary heart disease and metabolic syndrome, par-
ticularly hypertension and hyperglycemia were asso-
ciated with an increased risk of silent brain infarcts. 
A study conducted in neurologically healthy but el-
derly subjects showed that 15.7% of them had one or 
more ischemic lacunar lesions on magnetic resonance 
image, which corresponded to silent brain infarct. 
Hence, age and metabolic syndrome significantly 
correlated with the prevalence of silent brain infarct 
in apparently healthy older adults. According to the 
distribution of metabolic syndrome components, hy-
pertension showed strongest correlation with silent 
brain infarcts. positive trend between the number of 
metabolic components and silent brain infarct might 
serve as a diagnostic tool for prediction and preven-
tion of stroke35.
Efficacy of Lowering Triglyceride Levels
The Helsinki Heart study has shown the effi-
cacy of gemfibrozil in reducing triglyceride levels in 
patients with high basal triglyceride values by 43%, 
with greatest effect on coronary heart disease reduc-
tion. lowering triglycerides might have a positive ef-
fect in stroke risk reduction, although it is not clear 
whether it is independently related to relative stroke 
risk reduction or relative coronary heart disease risk 
reduction36.The greek Atorvastatin and Coronary 
Heart disease evaluation study (gReACe) was a 
randomized study, which included patients with coro-
nary heart disease. Atorvastatin reduced triglycerides 
by 31% and ldl-C level by 46%, and significant re-
duction was observed in mortality and stroke rates. in 
atorvastatin group, the relative stroke risk reduction 
was 47%. Although the reduction of stroke was very 
dramatic, multivariate analysis was not conducted, 
so it cannot be concluded whether the results arose 
from reduction in triglycerides, ldl-C levels or 
neuroprotective properties of atorvastatin37. The Vet-
erans Affairs High-density lipoprotein Cholesterol 
intervention trial (VA-Hit) compared gemfibrozil 
with placebo in men with coronary heart disease38. 
gemfibrozil was associated with significant relative 
risk reduction for tiA and carotid endarterectomy, 
reducing average triglyceride values by 31%. in later 
analysis of published VA-Hit studies, the relative 
risk reduction for ischemic stroke was highest in sub-
jects with low Hdl-C levels. The relative risk reduc-
tion for ischemic stroke was 28% in patients with trig-
lyceride level 1.7 mmol/l and 21% in patients with 
triglyceride levels >1.7 mmol/l. Results of VA-Hit 
and consequent analysis suggest that gemfibrozil can 
reduce the incidence of tiA and stroke in men with 
coronary heart disease and low Hdl-C38,39. gemfi-
brozil might reduce the risk of tiA and stroke due to 
its anti-inflammatory properties, which include stabi-
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lization of atherosclerotic plaques, reduction of factor 
Vii, thrombin and platelet reactivity38. Although it 
seems likely that triglyceride reduction in gReACe 
and VA-Hit contributed to the reduction of stroke, 
the effect of other factors cannot be excluded.
Conclusion
Current evidence suggests that hypertriglyceri-
demia correlates with an increased risk of cardiovas-
cular diseases, particularly if serum level of Hdl 
cholesterol is low40. The role of hypertriglyceridemia 
as an independent risk factor for stroke remains ques-
tionable, although correlation between elevated trig-
lycerides and recurrent ischemic stroke has been es-
tablished. According to available data, we conclude 
that there is substantial scientific evidence to presume 
that hypertriglyceridemia might be an independent 
risk factor for stroke, but additional studies are re-
quired to confirm this presumption.
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sažetak
HipeRtRigliCeRidemiJA kAo mogUći neZAVisni Čimbenik RiZikA ZA moŽdAni UdAR
M. Lisak, V. Demarin, Z. Trkanjec i V. Bašić Kes
nema pouzdanih podataka o povezanosti ishemijskog moždanog udara i povišene razine triglicerida u serumu. mo-
dificirajući čimbenici rizika za ishemijski moždani udar uključuju povišeni ukupni kolesterol, povišeni ldl te niski 
Hdl kolesterol. Uloga hipertrigliceridemije kao nezavisnog čimbenika rizika za nastanak moždanog udara je upitna, 
iako rezultati novijih istraživanja upućuju na to da hipertrigliceridemija korelira s povećanim rizikom za kardiovaskularne 
bolesti, osobito ako je koncentracija Hdl kolesterola niska, a ldl kolesterola povišena. Hipertrigliceridemija je ključna 
sastavnica metaboličkog sindroma, najvažnijeg čimbenika rizika za aterosklerozu i protrombozu koje su povezane s pove-
ćanim rizikom za nastanak moždanog udara. snižavanje povišenih triglicerida može imati pozitivan učinak u smanjenju 
rizika za moždani udar. Rezultati studija su pokazali djelotvornost gemfibrozila u smanjenju kardiovaskularnih događaja 
u bolesnika s koronarnom bolesti srca i povišenim trigliceridima te u sekundarnoj prevenciji moždanog udara. Fibrati se 
primjenjuju u primarnoj prevenciji moždanog udara u bolesnika s hipertrigliceridemijom, ali njihova učinkovitost nije 
dokazana. brojni dokazi upućuju na to da bi hipertrigliceridemija mogla biti nezavisan čimbenik rizika za moždani udar, 
ali za potvrdu ove pretpostavke potrebna su daljnja istraživanja.
ključne riječi: Hipertrigliceridemija; Rizični čimbenici; Moždani udar – prevencija i kontrola
